Top-Thema

08:34 Uhr
Marktüberblick: Dow Jones, DAX, Gold, WANT Index, Bayer, Thyssen, Dt. Wohnen, Rocket Internet, Metro

Stimmrechtsanteile: STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Freitag, 30.11.2018 12:55

DGAP Voting Rights Announcement: STADA Arzneimittel AG STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 30.11.2018 / 12:51 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings 1. Details of issuer
Name: STADA Arzneimittel AG
Street: Stadastraße 2-18
Postal code: 61118
City: Bad Vilbel Germany
Legal Entity Identifier (LEI): 529900FMTTLMH0P0DL10
2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:
3. Details of person subject to the notification obligation
Legal entity: Bain Capital Investors, LLC City of registered office, country: Wilmington, Delaware, United States of America (USA)
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.
Nidda Healthcare GmbH
5. Date on which threshold was crossed or reached:
28 Nov 2018
6. Total positions
  % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG
New 93.67 % 0.004 % 93.67 % 62,342,440
Previous notification 65.31 % 0.0008 % 65.31 % /
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG)
DE0007251803 58,398,885 % 93.67 %
Total 58,398,885 93.67 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Tender under domination and profit and loss transfer agreement n/a n/a 2,627 0.004 %
    Total 2,627 0.004 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
      Total %
8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Bain Capital Investors, LLC % % %
Bain Capital Partners Europe IV, L.P. % % %
Bain Capital Europe Fund IV, L.P. % % %
Universe Luxembourg S.C.A. % % %
Nidda Topco S.à r.l. % % %
Nidda Midco S.à r.l % % %
Nidda German Topco GmbH % % %
Nidda German Midco GmbH % % %
Nidda BondCo GmbH % % %
Nidda Healthcare Holding GmbH % % %
Nidda Healthcare GmbH 93.67 % % 93.67 %
 
Bain Capital Investors, LLC % % %
Bain Capital Partners Europe IV, L.P. % % %
Bain Capital Europe Fund IV, L.P. % % %
Universe Luxembourg GP S.à r.l. % % %
Universe Luxembourg S.C.A. % % %
Nidda Topco S.à r.l % % %
Nidda Midco S.à r.l % % %
Nidda German Topco GmbH % % %
Nidda German Midco GmbH % % %
Nidda BondCo GmbH % % %
Nidda Healthcare Holding GmbH % % %
Nidda Healthcare GmbH 93.67 % % 93.67 %
 
Bain Capital Investors, LLC % % %
Bain Capital Partners XI, L.P. % % %
Bain Capital Fund XI, L.P. % % %
Universe Luxembourg S.C.A. % % %
Nidda Topco S.à r.l. % % %
Nidda Midco S.à r.l % % %
Nidda German Topco GmbH % % %
Nidda German Midco GmbH % % %
Nidda BondCo GmbH % % %
Nidda Healthcare Holding GmbH % % %
Nidda Healthcare GmbH 93.67 % % 93.67 %
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %
10. Other explanatory remarks:
 
Date
29 Nov 2018

30.11.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de


Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Internet: www.stada.de
 
End of News DGAP News Service

753157  30.11.2018 

fncls.ssp?fn=show_t_gif&application_id=753157&application_name=news&site_id=ariva

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.